TY - JOUR
T1 - The Value of Rare Genetic Variation in the Prediction of Common Obesity in European Ancestry Populations
AU - Wang, Zhe
AU - Choi, Shing Wan
AU - Chami, Nathalie
AU - Boerwinkle, Eric
AU - Fornage, Myriam
AU - Redline, Susan
AU - Bis, Joshua C.
AU - Brody, Jennifer A.
AU - Psaty, Bruce M.
AU - Kim, Wonji
AU - McDonald, Merry Lynn N.
AU - Regan, Elizabeth A.
AU - Silverman, Edwin K.
AU - Liu, Ching Ti
AU - Vasan, Ramachandran S.
AU - Kalyani, Rita R.
AU - Mathias, Rasika A.
AU - Yanek, Lisa R.
AU - Arnett, Donna K.
AU - Justice, Anne E.
AU - North, Kari E.
AU - Kaplan, Robert
AU - Heckbert, Susan R
AU - de Andrade, Mariza
AU - Guo, Xiuqing
AU - Lange, Leslie A.
AU - Rich, Stephen S
AU - Rotter, Jerome I.
AU - Ellinor, Patrick T.
AU - Lubitz, Steven A.
AU - Blangero, John
AU - Shoemaker, M. Benjamin
AU - Darbar, Dawood
AU - Gladwin, Mark T.
AU - Albert, Christine M.
AU - Chasman, Daniel I.
AU - Jackson, Rebecca D.
AU - Kooperberg, Charles
AU - Reiner, Alexander P.
AU - O’Reilly, Paul F.
AU - Loos, Ruth J.F.
N1 - Publisher Copyright:
Copyright © 2022 Wang, Choi, Chami, Boerwinkle, Fornage, Redline, Bis, Brody, Psaty, Kim, McDonald, Regan, Silverman, Liu, Vasan, Kalyani, Mathias, Yanek, Arnett, Justice, North, Kaplan, Heckbert, de Andrade, Guo, Lange, Rich, Rotter, Ellinor, Lubitz, Blangero, Shoemaker, Darbar, Gladwin, Albert, Chasman, Jackson, Kooperberg, Reiner, O’Reilly and Loos.
PY - 2022/5/3
Y1 - 2022/5/3
N2 - Polygenic risk scores (PRSs) aggregate the effects of genetic variants across the genome and are used to predict risk of complex diseases, such as obesity. Current PRSs only include common variants (minor allele frequency (MAF) ≥1%), whereas the contribution of rare variants in PRSs to predict disease remains unknown. Here, we examine whether augmenting the standard common variant PRS (PRScommon) with a rare variant PRS (PRSrare) improves prediction of obesity. We used genome-wide genotyped and imputed data on 451,145 European-ancestry participants of the UK Biobank, as well as whole exome sequencing (WES) data on 184,385 participants. We performed single variant analyses (for both common and rare variants) and gene-based analyses (for rare variants) for association with BMI (kg/m2), obesity (BMI ≥ 30 kg/m2), and extreme obesity (BMI ≥ 40 kg/m2). We built PRSscommon and PRSsrare using a range of methods (Clumping+Thresholding [C+T], PRS-CS, lassosum, gene-burden test). We selected the best-performing PRSs and assessed their performance in 36,757 European-ancestry unrelated participants with whole genome sequencing (WGS) data from the Trans-Omics for Precision Medicine (TOPMed) program. The best-performing PRScommon explained 10.1% of variation in BMI, and 18.3% and 22.5% of the susceptibility to obesity and extreme obesity, respectively, whereas the best-performing PRSrare explained 1.49%, and 2.97% and 3.68%, respectively. The PRSrare was associated with an increased risk of obesity and extreme obesity (ORobesity = 1.37 per SDPRS, Pobesity = 1.7x10-85; ORextremeobesity = 1.55 per SDPRS, Pextremeobesity = 3.8x10-40), which was attenuated, after adjusting for PRScommon (ORobesity = 1.08 per SDPRS, Pobesity = 9.8x10-6; ORextremeobesity= 1.09 per SDPRS, Pextremeobesity = 0.02). When PRSrare and PRScommon are combined, the increase in explained variance attributed to PRSrare was small (incremental Nagelkerke R2 = 0.24% for obesity and 0.51% for extreme obesity). Consistently, combining PRSrare to PRScommon provided little improvement to the prediction of obesity (PRSrare AUC = 0.591; PRScommon AUC = 0.708; PRScombined AUC = 0.710). In summary, while rare variants show convincing association with BMI, obesity and extreme obesity, the PRSrare provides limited improvement over PRScommon in the prediction of obesity risk, based on these large populations.
AB - Polygenic risk scores (PRSs) aggregate the effects of genetic variants across the genome and are used to predict risk of complex diseases, such as obesity. Current PRSs only include common variants (minor allele frequency (MAF) ≥1%), whereas the contribution of rare variants in PRSs to predict disease remains unknown. Here, we examine whether augmenting the standard common variant PRS (PRScommon) with a rare variant PRS (PRSrare) improves prediction of obesity. We used genome-wide genotyped and imputed data on 451,145 European-ancestry participants of the UK Biobank, as well as whole exome sequencing (WES) data on 184,385 participants. We performed single variant analyses (for both common and rare variants) and gene-based analyses (for rare variants) for association with BMI (kg/m2), obesity (BMI ≥ 30 kg/m2), and extreme obesity (BMI ≥ 40 kg/m2). We built PRSscommon and PRSsrare using a range of methods (Clumping+Thresholding [C+T], PRS-CS, lassosum, gene-burden test). We selected the best-performing PRSs and assessed their performance in 36,757 European-ancestry unrelated participants with whole genome sequencing (WGS) data from the Trans-Omics for Precision Medicine (TOPMed) program. The best-performing PRScommon explained 10.1% of variation in BMI, and 18.3% and 22.5% of the susceptibility to obesity and extreme obesity, respectively, whereas the best-performing PRSrare explained 1.49%, and 2.97% and 3.68%, respectively. The PRSrare was associated with an increased risk of obesity and extreme obesity (ORobesity = 1.37 per SDPRS, Pobesity = 1.7x10-85; ORextremeobesity = 1.55 per SDPRS, Pextremeobesity = 3.8x10-40), which was attenuated, after adjusting for PRScommon (ORobesity = 1.08 per SDPRS, Pobesity = 9.8x10-6; ORextremeobesity= 1.09 per SDPRS, Pextremeobesity = 0.02). When PRSrare and PRScommon are combined, the increase in explained variance attributed to PRSrare was small (incremental Nagelkerke R2 = 0.24% for obesity and 0.51% for extreme obesity). Consistently, combining PRSrare to PRScommon provided little improvement to the prediction of obesity (PRSrare AUC = 0.591; PRScommon AUC = 0.708; PRScombined AUC = 0.710). In summary, while rare variants show convincing association with BMI, obesity and extreme obesity, the PRSrare provides limited improvement over PRScommon in the prediction of obesity risk, based on these large populations.
KW - BMI - body mass index
KW - C+T
KW - PRS-CS
KW - burden score
KW - lassosum
KW - obesity risk
KW - polygenic risk score
KW - rare variants
UR - http://www.scopus.com/inward/record.url?scp=85130368867&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85130368867&partnerID=8YFLogxK
U2 - 10.3389/fendo.2022.863893
DO - 10.3389/fendo.2022.863893
M3 - Article
C2 - 35592775
AN - SCOPUS:85130368867
SN - 1664-2392
VL - 13
JO - Frontiers in Endocrinology
JF - Frontiers in Endocrinology
M1 - 863893
ER -